Health Care · Biological Products, (No Diagnostic Substances) · Nasdaq · CIK 2007919 · FYE Dec 31 · Prices AT CLOSE 2026-08-19 (USD) Last $101.48 · Day +7.25% · Mkt cap $1.4B · 1Y +341.2% · Off 52W high −34.7% · Vol (1Y) 131.2% Price2023-08-21 → 2026-08-19 INBX close: $42 on 2023-08-21 to $101 on 2026-08-19. Split-adj closes · 240 of 1,374 · price returnⓘ At a glance | Short interest22.7% of sh out | | Days to cover15.6d | | 13F net flow (QoQ)+2.43% | | Top-10 13F concentration69.3% | | Next report (est.)2026-11-13 |
SI 2026-07-31 · 13F 2026-Q1ⓘ Key fundamentalsFY 2025 | Sales (TTM)$1.3M | | Earnings (TTM)-$138.2M | | ROE−197.8% | | Net margin−10773.5% | | Debt / equity12.58× |
FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns | YTD+28.5% | | 1Y+341.2% | | 3Y+143.3% | | 5Y+59.0% | | Since incept. (ann.)+10.0% |
Total return · from 2021-02-22ⓘ Risk | Ann. volatility (1Y)131.2% | | Ann. volatility (3Y)102.4% | | Sharpe (1Y)1.62 | | Sharpe (3Y)0.96 | | Max drawdown (1Y)−44.1% | | Max drawdown (3Y)−87.6% | | Beta (3Y vs SPY)2.96 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 | Manager | Shares | Value | % sh out | QoQ |
|---|
| PERCEPTIVE ADVISORS LLC | 1.4M | $97M | 9.88% | −0.7% | | VIKING GLOBAL INVESTORS LP | 1.4M | $97M | 9.84% | +0.0% | | MORGAN STANLEY | 1.3M | $85M | 8.65% | +8.2% | | Sanofi | 1.2M | $78M | 7.93% | +0.0% | | HighTower Advisors, LLC | 870,200 | $59M | 5.96% | −0.0% | | BlackRock, Inc. | 798,898 | $54M | 5.47% | +2.8% | | STATE STREET CORP | 550,845 | $37M | 3.77% | +46.9% | | VANGUARD CAPITAL MANAGEMENT LLC | 486,422 | $33M | 3.33% | new |
Δ vs 2025-Q4ⓘ Latest reported quarterslast report 2026-08-13 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-06-30 | 2026-08-13 | −$2.34 | — | $0 | −100.0% | | 2026-03-31 | 2026-05-14 | −$2.15 | — | — | — | | 2025-12-31 | 2026-03-19 | — | — | $0 | −100.0% | | 2025-09-30 | 2025-11-14 | −$2.28 | — | $0 | — |
As-reported XBRL · next 2026-11-13 est.ⓘ Segment mixFY2025 (ended Dec 2025) Reportable 100% business · TAGGED revenueⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
|
